Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crane NXT (CXT) Cash & Equivalents (2016 - 2025)

Crane NXT (CXT) has disclosed Cash & Equivalents for 17 consecutive years, with $233.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 41.01% year-over-year to $233.8 million, compared with a TTM value of $233.8 million through Dec 2025, up 41.01%, and an annual FY2025 reading of $233.8 million, up 41.01% over the prior year.
  • Cash & Equivalents was $233.8 million for Q4 2025 at Crane NXT, up from $182.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $650.6 million in Q2 2022 and bottomed at $152.5 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $311.7 million, with a median of $232.2 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents soared 91.02% in 2021, then tumbled 57.44% in 2023.
  • Year by year, Cash & Equivalents stood at $478.6 million in 2021, then crashed by 51.8% to $230.7 million in 2022, then dropped by 1.52% to $227.2 million in 2023, then dropped by 27.02% to $165.8 million in 2024, then skyrocketed by 41.01% to $233.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for CXT at $233.8 million in Q4 2025, $182.4 million in Q3 2025, and $152.5 million in Q2 2025.